TRAMADOL Drug Patent Profile
✉ Email this page to a colleague
When do Tramadol patents expire, and when can generic versions of Tramadol launch?
Tramadol is a drug marketed by Actavis Elizabeth, Aurobindo Pharma Ltd, Endo Operations, Lupin Ltd, Macleods Pharms Ltd, Mylan, Strides Pharma, Sun Pharm, Accord Hlthcare, Amneal Pharms, Apotex, Asta, Cspc Ouyi Pharm Co, Graviti Pharms, Ipca Labs Ltd, Ivax Sub Teva Pharms, Merro Pharm Usa, Mylan Pharms Inc, Northstar Hlthcare, Pliva, Rubicon, Specgx Llc, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Unichem, Watson Labs, Zydus Pharms Usa Inc, Alkem Labs Ltd, Aurobindo Pharma, Chartwell Rx, Micro Labs Ltd India, Nostrum Labs Inc, and Rising. and is included in forty-five NDAs.
The generic ingredient in TRAMADOL is acetaminophen; tramadol hydrochloride. There are sixty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the acetaminophen; tramadol hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAMADOL?
- What are the global sales for TRAMADOL?
- What is Average Wholesale Price for TRAMADOL?
Summary for TRAMADOL
US Patents: | 0 |
Applicants: | 34 |
NDAs: | 45 |
Drug Prices: | Drug price information for TRAMADOL |
Drug Sales Revenues: | Drug sales revenues for TRAMADOL |
DailyMed Link: | TRAMADOL at DailyMed |


